What is the recommended treatment regimen for syphilis, including early infection, late latent disease, neurosyphilis, and pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Syphilis Treatment

Benzathine penicillin G remains the definitive treatment for all stages of syphilis, with dosing and duration determined by disease stage: single 2.4 million unit IM dose for early infection, three weekly 2.4 million unit IM doses for late latent disease, and IV aqueous penicillin G or ceftriaxone for neurosyphilis. 1

Treatment by Stage

Early Syphilis (Primary, Secondary, and Early Latent <1 year)

  • Benzathine penicillin G 2.4 million units IM as a single dose 1
  • This applies to patients with documented infection acquired within the preceding year based on:
    • Documented seroconversion
    • Unequivocal symptoms of primary or secondary syphilis
    • Sex partner with confirmed early syphilis

For penicillin-allergic non-pregnant patients: Doxycycline 100 mg orally twice daily for 14 days OR tetracycline 500 mg orally four times daily for 14 days 2, 3

Late Latent Syphilis or Latent Syphilis of Unknown Duration

  • Benzathine penicillin G 7.2 million units total: three doses of 2.4 million units IM given at 1-week intervals 1
  • Patients who cannot be definitively classified as early latent should be treated as late latent

For penicillin-allergic non-pregnant patients: Doxycycline 100 mg orally twice daily for 28 days OR tetracycline 500 mg orally four times daily for 28 days 1, 3

Critical caveat: If a patient misses a dose during weekly therapy, an interval of 10-14 days between doses may be acceptable before restarting the sequence. However, pregnant patients who miss any dose must repeat the full course of therapy 1

Tertiary Syphilis (Gumma and Cardiovascular)

  • Benzathine penicillin G 7.2 million units total: three doses of 2.4 million units IM at 1-week intervals 1
  • Note: This does NOT include neurosyphilis, which requires different treatment
  • Patients with symptomatic late syphilis should have CSF examination before therapy
  • Some experts treat all cardiovascular syphilis with a neurosyphilis regimen 1

Neurosyphilis

Neurosyphilis requires IV therapy and can occur at any stage of syphilis 1

While the provided guidelines reference neurosyphilis treatment, specific regimens are noted to be in separate sections. Based on standard practice and the guideline framework:

  • Aqueous crystalline penicillin G 18-24 million units per day (administered as 3-4 million units IV every 4 hours or continuous infusion) for 10-14 days is the standard regimen
  • Syphilitic uveitis or other ocular manifestations are treated as neurosyphilis 1

Indications for CSF examination:

  • Neurologic or ophthalmic signs/symptoms
  • Evidence of active tertiary syphilis (aortitis, gumma, iritis)
  • Treatment failure
  • HIV infection with late latent syphilis or syphilis of unknown duration 1
  • Some specialists recommend CSF examination for all patients with nontreponemal titers >1:32 1

Pregnancy

Pregnant patients MUST receive penicillin regardless of allergy status 1

  • Penicillin-allergic pregnant patients should be desensitized and treated with penicillin 1
  • No alternative antibiotics are acceptable in pregnancy
  • Screening should occur three times: at first prenatal visit, during third trimester, and at delivery 4
  • Missed doses are unacceptable—full course must be repeated 1

Pediatric Dosing

Children require CSF examination to exclude neurosyphilis and review of birth/maternal records to distinguish congenital from acquired syphilis 1

Early latent syphilis:

  • Benzathine penicillin G 50,000 units/kg IM (up to adult dose of 2.4 million units) as single dose 1

Late latent or unknown duration:

  • Benzathine penicillin G 50,000 units/kg IM (up to adult dose of 2.4 million units) given as three doses at 1-week intervals (total 150,000 units/kg up to 7.2 million units) 1

Follow-Up and Treatment Response

Quantitative nontreponemal serologic tests (RPR/VDRL) should be repeated at 6,12, and 24 months 1

Retreatment is indicated if:

  • Titers increase fourfold
  • Initially high titer (≥1:32) fails to decline at least fourfold within 12-24 months
  • Signs or symptoms attributable to syphilis develop 1

Use the same nontreponemal test throughout follow-up for accurate comparison 5

Special Populations and Considerations

HIV-Infected Patients

  • Same penicillin regimens as HIV-negative patients 1
  • CSF examination recommended for late latent syphilis or syphilis of unknown duration 1
  • Efficacy of alternative (non-penicillin) regimens has not been well studied and should be used with caution 1
  • More frequent follow-up (3,6,12,24 months) is common practice 5

Key Clinical Pitfalls

  1. Do not use macrolides due to potential resistance 5
  2. Single-dose ceftriaxone is NOT effective for treating syphilis 6
  3. All syphilis patients should be tested for HIV 1
  4. Screen all sexual contacts and treat as appropriate 3
  5. Recent evidence suggests that for high-titer late latent syphilis (>1:32), single-dose benzathine penicillin G may have similar serological outcomes to three-dose regimens, though this contradicts current guidelines and requires further validation 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.